SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-127952
Filing Date
2020-11-20
Accepted
2020-11-20 16:10:52
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2036053d1_10q.htm 10-Q 1119722
2 EXHIBIT 31.1 tm2036053d1_ex31-1.htm EX-31.1 9199
3 EXHIBIT 31.2 tm2036053d1_ex31-2.htm EX-31.2 9046
4 EXHIBIT 32.1 tm2036053d1_ex32-1.htm EX-32.1 4565
5 EXHIBIT 32.2 tm2036053d1_ex32-2.htm EX-32.2 4656
  Complete submission text file 0001104659-20-127952.txt   4291030

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT azyo-20200930.xml EX-101.INS 670987
7 XBRL TAXONOMY EXTENSION SCHEMA azyo-20200930.xsd EX-101.SCH 43147
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azyo-20200930_cal.xml EX-101.CAL 43406
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azyo-20200930_def.xml EX-101.DEF 135432
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20200930_lab.xml EX-101.LAB 353413
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20200930_pre.xml EX-101.PRE 270096
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 201332603
SIC: 2836 Biological Products, (No Diagnostic Substances)